A Comprehensive Look At The Epidemiology & Clinical Characteristics Of Monkeypox In The GeoSentinel Network: What We Know So Far From The GeoSentinel Network
To date, the GeoSentinel Network has identified 893 cases of monkeypox from 46 countries. The majority of cases (70%) have been reported from Africa, with the Democratic Republic of Congo (DRC) accounting for nearly half of all cases. Other countries with high numbers of reported cases include Nigeria (19%), Ivory Coast (6%), and Ghana (5%). Cases have also been reported from Europe (4%), North America (3%), Asia (2%), and South America (1%).
The median age of patients with monkeypox is 28 years old, and 63% of patients are male. The most common symptoms include fever (88%), rash (75%), lymphadenopathy (69%), headache (48%), and myalgia (45%). Monkeypox can range from a self-limited illness to a more severe illness requiring hospitalization; however, death is rare, with a case fatality rate of less than 1%.
The GeoSentinel Network has been essential in helping to understand the epidemiology and clinical characteristics of monkeypox. This information is critical for developing better diagnostic tools and treatments for this disease.
Epidemiology of Monkeypox in the GeoSentinel Network
The GeoSentinel Network has been monitoring monkeypox cases since 1996. There have been a total of 922 monkeypox cases reported to the network, with the majority of cases occurring in Africa. The epidemiology of monkeypox in the GeoSentinel Network is as follows:
The average age of patients with monkeypox is 33 years old. The majority of patients are male (61%). Cases have been reported from 31 countries, with the highest number of cases coming from the Democratic Republic of Congo (DRC) (n=298), Nigeria (n=226), and Cameroon (n=115). The case fatality ratio for monkeypox is 3%. The most common symptoms reported are fever (96%), rash (93%), and lymphadenopathy (74%). Other less common symptoms include headache, myalgia, arthralgia, nausea, vomiting, and chest pain. Hospitalization rates are high, with 74% of patients being hospitalized. Pneumonia is the most common complication, occurring in 22% of patients. Other complications include sepsis (9%), encephalitis (2%), and death (3%).
Clinical Characteristics of Monkeypox in the GeoSentinel Network
Since the first reports of human monkeypox in the 1970s, there have been sporadic outbreaks of the disease in Africa. The majority of cases occur in rural areas of the Congo Basin, with occasional spillover into other countries in Central and West Africa. In recent years, there have been several large outbreaks of monkeypox, including one in the Democratic Republic of Congo (DRC) in 2017 that affected nearly 400 people.
Monkeypox is the most viral infection that is transmitted from animals to humans. The primary animal reservoirs for monkeypox are rodents and primates, although other animals such as bats and squirrels can also be infected. Human-to-human transmission is thought to occur through close contact with an infected person or their belongings, although the exact mode of transmission is not fully understood.
The illness begins with a fever, followed by a rash that progresses from small raised bumps (papules) to large blisters (vesicles). Other common symptoms include headache, muscle pain, lymphadenopathy (enlarged lymph nodes), and conjunctivitis (red eyes). Severe cases can lead to pneumonia, encephalitis (inflammation of the brain), and death.
There is no specific treatment for monkeypox and no vaccine available for prevention. Treatment focuses on relief.
What are the symptoms?
The incubation period for monkeypox is usually 7-14 days, but can be as long as 21 days. The illness begins with a fever, followed by a rash that typically starts on the face and spreads to the rest of the body. The rash starts as small red bumps that turn into vesicles (fluid-filled blisters) and then pustules (pus-filled blisters). Lesions may also form inside the mouth, nose, and throat.
There is no specific treatment for monkeypox and no vaccine is available outside of Africa. However, smallpox vaccines have been shown to be effective in preventing monkeypox infection or reducing its severity.
Causes of Infection & Risk Factors for Transmission
It is believed to have originated in Africa, where it is still endemic in some countries. The monkeypox virus is closely related to the human variola virus, which caused the smallpox pandemic. However, there are still stores of the smallpox virus in research laboratories around the world.
The monkeypox virus can infect humans and animals. It is most commonly found in wild rodents and primates, such as monkeys and apes. The virus can be transmitted to humans through contact with infected animals, such as through a bite or scratch, or through contact with infected animal tissues or body fluids. Monkeypox can also be spread from person to person through close contact with an infected individual, such as through coughing or sneezing.
The incubation period for monkeypox is usually about 10 days but can range from 5-21 days. The illness typically begins with fever, headache, muscle aches, and chills. A rash then develops, starting on the face and spreading to other parts of the body. The rash typically goes through three stages: first bumps appear, then they turn into fluid-filled blisters, and finally the blisters scab over. Monkeypox is often mistaken for chickenpox at first because of these similarities. However, monkeypox tends to be more severe, with a higher fever and more extensive rash
Is there a vaccine?
Yes, there is a vaccine for monkeypox, but it is not yet licensed in the United States. The vaccine is called ACAM2000 and was developed by the U.S. It is derived from the smallpox vaccine and has been shown to be effective in preventing monkeypox infection in animals.
Diagnosis and Treatment of Monkeypox
Monkeypox is a zoonotic disease caused by the Monkeypox virus. The virus is transmitted from animals to humans through contact with infected animal products or close contact with an infected person. The incubation period for Monkeypox is typically 7-14 days but can range from 5-21 days. The rash typically starts on the face and spreads to the trunk and extremities. Monkeypox can be severe and sometimes fatal. Prevention of Monkeypox is through vaccination with the smallpox vaccine or avoidance of exposure to animals or humans with Monkeypox.
How the GeoSentinel Network is Helping with Monitoring and
The GeoSentinel Network is a global surveillance system for monitoring the epidemiology and clinical characteristics of monkeypox. The network includes over 1,000 sites in more than 100 countries and monitors cases of monkeypox reported by sentinel clinics. The data collected by the network helps to assess the risk of exposure to monkeypox and to identify potential outbreaks. The GeoSentinel Network has been instrumental in identifying several outbreaks of monkeypox, including the 2014 outbreak in the Democratic Republic of Congo. The data collected by the network has also helped to improve our understanding of the epidemiology and clinical course of monkeypox.
Since the last report on monkeypox in the GeoSentinel Network in 2009, there have been 31 cases of monkeypox reported from 11 countries. The majority of cases (23/31) were reported from the Democratic Republic of Congo (DRC), with the remaining cases occurring in Cameroon (2), Central African Republic (1), Ghana (1), Nigeria (1), Sudan (1), and Uganda (2). Of the 31 cases, 28 were travel-related and 3 were contacts of known cases.
The majority of cases occurred in adults aged 30-49 years (19/31); however, there was a wide age range from 1-67 years. The median incubation period was 12 days (range of 3-21 days). The most common clinical features were fever (84%), rash (77%), lymphadenopathy (48%), and headache (42%). Other less common features included myalgia, arthralgia, ocular symptoms, oral ulcerations, and edema. The rash typically started on the face and progressed to involve the trunk and extremities.
Of the 31 cases, 29 were confirmed by laboratory testing and 2 were probable based on clinical diagnosis. Monkeypox should be considered in any patient with a febrile illness and a vesicular or pustular rash, especially if travel to an endemic area has occurred within 21 days prior to illness onset. Early diagnosis and treatment is essential to prevent serious morbidity and mortality associated with this disease.
Tags:
EPIDEMIOLOGY